This inventor holds 25 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent, primarily in Controlled Release Formulations. Top assignees: Andrx Pharmaceuticals, Inc., Andrx Labs, LLC, Andrx Corporation, Inc.. Active years: 2000-2016.
Location History:
- Weston, FL (US) (2005 - 2014)
- Davie, FL (US) (2000 - 2016)
Company Filing History:
15 out of 58 
5 out of 10 
3 out of 8 
Years Active: 2000-2016
Areas of Expertise:
Title: Innovations of Xiu Xiu Cheng: A Pioneer in Controlled Release Formulations
Introduction
Xiu Xiu Cheng, based in Weston, Florida, is an accomplished inventor with a notable portfolio of 25 patents. His contributions primarily focus on advanced pharmaceutical formulations, particularly in the realm of controlled release dosage forms. Cheng has made a significant impact on the development of medications that optimize therapeutic efficacy while minimizing side effects.
Latest Patents
Among his most recent patents is the invention of an oral controlled release dosage form aimed at the administration of central nervous system stimulants, specifically methylphenidate hydrochloride. This invention provides a controlled release mechanism that enhances the effectiveness of the medication. Another innovative formulation developed by Cheng is the controlled release diltiazem dosage formulation, which incorporates a plurality of diltiazem pellets and a gel-forming material. This formulation ensures that the peak blood plasma levels of diltiazem occur more than 8 hours, and ideally over 10 hours in some cases, post-administration.
Career Highlights
Cheng has played a significant role in the pharmaceutical industry, having worked with prominent companies such as Andrx Pharmaceuticals, Inc. and Andrx Labs, LLC. His experience in these organizations has given him a wealth of knowledge and expertise in pharmaceutical development, particularly in drug formulation and delivery technologies.
Collaborations
Throughout his career, Cheng has collaborated with talented individuals in the field, including notable colleagues such as Chih-Ming Chen and Steve Jan. These partnerships have contributed to innovative advancements in drug formulation, reflecting the importance of teamwork in achieving groundbreaking pharmaceutical solutions.
Conclusion
Xiu Xiu Cheng's contributions to the field of controlled release formulations are noteworthy and exemplify the role of inventors in advancing healthcare. With 25 patents to his name, his ongoing innovations continue to improve the efficacy of medications, benefiting patients and the pharmaceutical industry alike. As his career progresses, it will be interesting to observe how Cheng's work continues to evolve and shape the future of drug delivery systems.